Allan I. Levey, MD, PhD

Sponsored Research Projects

• A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease
• A Phase III, Randomized, Placebo-Controlled, Parallel-Group, Double-Blind Clinical Trial to Study the Efficacy and Safety of MK-8931 (SCH 900931) in Subjects With Amnestic Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal AD)
• Alzheimers Disease Neuroimaging Initative-2 (ADNI-2)
• An Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's Disease
• Blinded Long-term Extension Study to Evaluate the Safety and Efficacy of Pioglitazone
• BN29552: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled
• Effects of Traumatic Brain Injury and Post-Traumatic Stress Disorder and Alzheimer
• National Alzheimer's Coordinating Center (NACC)
• The Emory Alzheimer's Disease Research Center